Randomized phase 3 trial evaluating KAT6 inhibitor PF-07248144 plus fulvestrant in HR plus HER- advanced/ metastatic breast cancer after progression on CDK4/6 inhibitor-based therapy
  • Oliveira, M.
  • Layman, R. M.
  • Giordano, A.
  • Mukohara, T.
  • Park, Y. H.
  • 외 11명
Citations

WEB OF SCIENCE

0
제목
Randomized phase 3 trial evaluating KAT6 inhibitor PF-07248144 plus fulvestrant in HR plus HER- advanced/ metastatic breast cancer after progression on CDK4/6 inhibitor-based therapy
저자
Oliveira, M.Layman, R. M.Giordano, A.Mukohara, T.Park, Y. H.Lindeman, G.Bianchini, G.De Nonneville, A.Dieras, V. C.Kuemmel, S.Kahn, A.Tao, J.Kent, S.Davis, G. M.Li, M.Kalinsky, K. M.
DOI
10.1016/j.annonc.2025.08.1039
발행일
2025-09
유형
Meeting Abstract
저널명
Annals of Oncology
36